News

Digital Therapeutics Alliance and Healthware Group Partner to Build European Coalition to Scale Access to Digital Therapeutics

ARLINGTON, Va. & MILAN, Italy--(BUSINESS WIRE)--The Digital Therapeutics Alliance (DTA) and Healthware Group today announced a partnership to form a…

2 years ago

Canadian Dental Hygienists Association Releases Policy Paper on a National Oral Health Care Plan for Canadian Seniors

Ottawa, Ontario--(Newsfile Corp. - June 14, 2022) - In a policy paper released today, the Canadian Dental Hygienists Association (CDHA)…

2 years ago

Evotec Enters a Drug Discovery Collaboration with Janssen

STRATEGIC PARTNERSHIP LEVERAGES EVOTEC'S PROPRIETARY PLATFORM CAPABILITIES IN THE FIELD OF PROTEIN HOMEOSTASISHAMBURG, GERMANY / ACCESSWIRE / June 14, 2022…

2 years ago

CONMED Completes Acquisition of In2Bones Global, Inc.

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held In2Bones Global…

2 years ago

Outset Medical Announces Shipment Hold on New Tablo Systems for Home Use Pending FDA Review and Clearance of Recent 510(K) Submission

Investor Webcast and Conference Call Scheduled for 5:00 p.m. EST SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or…

2 years ago

9 Meters Biopharma to Participate in the 2022 BIO International Convention

RALEIGH, NC / ACCESSWIRE / June 13, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments…

2 years ago

Tivic Health Announces Annual Meeting of Shareholders

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today…

2 years ago

Blue Goji to Demonstrate Embodied eSports with Expresso, CyberCycle, Embodi Bikes and to Preview Embodied Health Services at IHRSA 2022

AUSTIN, Texas--(BUSINESS WIRE)--Blue Goji®, a health technology company, will host Embodied eSports demonstrations and prize-winning tournaments with its recently-acquired Expresso®,…

2 years ago

Altamira Therapeutics Announces Top-Line Data from AM-125 Phase 2 Study in Acute Vertigo

Significant improvement in balance after four-week treatment with AM-125 20 mg nasal spray vs. placeboStudy provides proof-of-concept for enhancement and…

2 years ago

The Last Clinic Visit Conducted in Promore Pharma’s Phase II Study of Ensereptide

STOCKHOLM, SE / ACCESSWIRE / June 13, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)STOCKHOLM, 13 June 2022 - Promore Pharma AB…

2 years ago